News Focus
News Focus
icon url

Tatsumaki

01/10/24 12:24 PM

#420120 RE: the_kube #420118

I'd rather they spent $50M expanding MND-2119 than padding BOD stock option values.
icon url

Chromosome

01/10/24 12:25 PM

#420122 RE: the_kube #420118

Agreed plus not promoting in the US…I was very pleasantly surprised by Q4 revenue estimate (72-74). If they can generate positive cash flow every quarter, by the time they can legally repurchase shares (Q3 24), they can use generated cash to repurchase over time.
icon url

Denisk

01/10/24 1:29 PM

#420146 RE: the_kube #420118

so you are assuming buying back stock at $1.00 a share, right?